Gadoyeva Dilshoda Abdigaffor kizi (1)
Background: Mid-urethral sling (MUS) procedures, including tension-free vaginal tape (TVT) and transobturator tape (TOT), have become the gold standard in the surgical treatment of stress urinary incontinence (SUI). With rising global concerns about mesh safety, the long-term outcomes of these interventions have gained renewed importance.
Aim: To evaluate prolonged (≥5–10 year) postoperative outcomes of TVT and TOT procedures using evidence published between 2020 and 2025.
Methods: A structured review of randomized controlled trials, cohort studies, national registry analyses, imaging studies, and case reports from 2020–2025. The primary endpoints included long-term efficacy, recurrence, complications, mesh-related events, quality of life outcomes, and reoperation rates.
Results: Long-term follow-up data indicate sustained improvement in continence rates after both TVT and TOT, with retropubic TVT demonstrating slightly higher durability in some cohorts. Complication patterns differ: TOT is associated with groin pain, while TVT has higher rates of voiding dysfunction and bladder injury. Late mesh exposure, de novo urgency, and occasional erosions beyond 10 years are documented. Patient satisfaction remains high (>70%) at 10–20 years but declines gradually with time.
Conclusion: Both TVT and TOT remain effective long-term treatments for SUI, but complications may arise even after a decade. Individualized patient selection, long-term follow-up, and improved management strategies for mesh complications are essential.
1. Abrams P, et al. International Consultation on Incontinence. 2020.
2. Alatawi M, et al. Clinical outcomes after MUS. CEOG. 2024.
3. Alexandridis V, et al. 10-year outcomes after MUS. 2022.
4. Cox A, et al. Long-term complications of MUS. 2020.
5. de Carvalho JB, et al. Long-term MUS evaluation. Eur J Obstet Gynecol. 2023.
6. Drobot RB, et al. Robotic mesh excision case study. Videosurgery. 2025.
7. FDA Mesh Safety Communication. 2020.
8. Ford AA, et al. Mid-urethral sling operations. Cochrane Review. 2020.
9. Gadoyeva D. A., Najmutdinova D. K., Irnazarova D.Kh. // Role of autologous platelet rich plasma in modern medicine // Journal of Healthcare and Life-Science Research. – Tashkent, 2023. Volume 2, issue 12, pp 184-187. ISSN: 2181-4368
10. Gadoyeva D. A., Najmutdinova D. K., Irnazarova D.Kh. Changes in cytokine profile after surgery // EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE. – Belgium, 2023. Volume 3, issue 12, pp 69-74. ISSN: 2795-921X
11. Guillot-Tantay C, et al. National database long-term MUS safety. eClinicalMedicine. 2025.
12. Isenlik Ü, et al. Long-term TOT surgery outcomes. Pelviperineology. 2024.
13. Laycock J, et al. Ultrasound in MUS complication assessment. J Clin Med. 2024.
14. Maher C, et al. Surgical management of SUI. 2021.
15. Milsom I, et al. Long-term continence trends. 2021.
16. Najmutdinova D. K., Gadoyeva D. A. Pelvic Organ Prolapse // International Journal on Integrated Education. – USA, 2022. Volume 5, issue 9, pp 12-16. ISSN: 2620-3502.
17. Najmutdinova D. K., Gadoyeva D. A. Post surgery period after anterior colporrhaphy, posterior colpoperineolevatoroplasty in a group of women with different ages // CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – Spain, 2023. Volume 4, issue 3, pp 312-315. ISSN: 2660-4159.
18. Najmutdinova D. K., Kamilova I.A., Gadoyeva D. A. Benefits of using PRP therapy in various gynecological diseases // CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – Spain, 2023. Volume 3, issue 6, pp 392-394. ISSN: 2660-4159.
19. Nilsson CG, et al. 20–25 year TVT follow-up. BJOG. 2024.
20. Palva K, et al. 16-year RCT of TVT vs TOT. 2022.
21. Serati M, et al. Comparative long-term outcomes of TVT and TOT. Int Urogynecol J. 2021.